Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.17
HLS's Cash to Debt is ranked higher than
68% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. HLS: 0.17 )
HLS' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.17

Equity to Asset 0.16
HLS's Equity to Asset is ranked higher than
54% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. HLS: 0.16 )
HLS' s 10-Year Equity to Asset Range
Min: -0.77   Max: 0.59
Current: 0.16

-0.77
0.59
Interest Coverage 4.80
HLS's Interest Coverage is ranked higher than
69% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 5.04 vs. HLS: 4.80 )
HLS' s 10-Year Interest Coverage Range
Min: 0.29   Max: 9999.99
Current: 4.8

0.29
9999.99
F-Score: 4
Z-Score: 1.57
M-Score: -3.02
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 20.40
HLS's Operating margin (%) is ranked higher than
95% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 9.13 vs. HLS: 20.40 )
HLS' s 10-Year Operating margin (%) Range
Min: -3.55   Max: 37.8
Current: 20.4

-3.55
37.8
Net-margin (%) 9.79
HLS's Net-margin (%) is ranked higher than
86% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 4.95 vs. HLS: 9.79 )
HLS' s 10-Year Net-margin (%) Range
Min: -36.52   Max: 48.3
Current: 9.79

-36.52
48.3
ROE (%) 60.70
HLS's ROE (%) is ranked higher than
100% of the 289 Companies
in the Global Medical Care industry.

( Industry Median: 10.03 vs. HLS: 60.70 )
HLS' s 10-Year ROE (%) Range
Min: -22.44   Max: 1312.58
Current: 60.7

-22.44
1312.58
ROA (%) 8.80
HLS's ROA (%) is ranked higher than
91% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 3.91 vs. HLS: 8.80 )
HLS' s 10-Year ROA (%) Range
Min: -17.98   Max: 44.36
Current: 8.8

-17.98
44.36
ROC (Joel Greenblatt) (%) 41.29
HLS's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 18.78 vs. HLS: 41.29 )
HLS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -17.71   Max: 129.42
Current: 41.29

-17.71
129.42
Revenue Growth (3Y)(%) 8.70
HLS's Revenue Growth (3Y)(%) is ranked higher than
79% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. HLS: 8.70 )
HLS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -27   Max: 8.7
Current: 8.7

-27
8.7
EBITDA Growth (3Y)(%) 17.30
HLS's EBITDA Growth (3Y)(%) is ranked higher than
90% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. HLS: 17.30 )
HLS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 19.8
Current: 17.3

0
19.8
EPS Growth (3Y)(%) -34.80
HLS's EPS Growth (3Y)(%) is ranked higher than
57% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 10.90 vs. HLS: -34.80 )
HLS' s 10-Year EPS Growth (3Y)(%) Range
Min: -47.9   Max: 56
Current: -34.8

-47.9
56
» HLS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

HLS Guru Trades in Q4 2013

Vanguard Health Care Fund 24,624 sh (New)
Steven Cohen 34,975 sh (New)
Paul Tudor Jones 18,428 sh (New)
Jim Simons 581,500 sh (+130.3%)
Chuck Royce 773,500 sh (unchged)
Joel Greenblatt Sold Out
James Barrow 3,006,913 sh (-1.5%)
Mariko Gordon 2,334,292 sh (-2.7%)
Columbia Wanger 2,541,000 sh (-22.55%)
» More
Q1 2014

HLS Guru Trades in Q1 2014

Jim Simons 595,800 sh (+2.46%)
Columbia Wanger 2,541,000 sh (unchged)
Paul Tudor Jones Sold Out
Vanguard Health Care Fund Sold Out
Steven Cohen Sold Out
James Barrow 2,990,363 sh (-0.55%)
Chuck Royce 734,800 sh (-5%)
Mariko Gordon 1,874,476 sh (-19.7%)
» More
Q2 2014

HLS Guru Trades in Q2 2014

Paul Tudor Jones 6,324 sh (New)
Jim Simons 785,200 sh (+31.79%)
Chuck Royce 796,313 sh (+8.37%)
Mariko Gordon 1,863,584 sh (-0.58%)
Columbia Wanger 2,526,100 sh (-0.59%)
James Barrow 2,890,653 sh (-3.33%)
» More
Q3 2014

HLS Guru Trades in Q3 2014

Paul Tudor Jones 13,585 sh (+114.82%)
Jim Simons 971,400 sh (+23.71%)
Columbia Wanger 2,519,800 sh (-0.25%)
Mariko Gordon 1,857,733 sh (-0.31%)
Chuck Royce 756,513 sh (-5%)
James Barrow 2,401,883 sh (-16.91%)
» More
» Details

Insider Trades

Latest Guru Trades with HLS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2014-03-31 Reduce -19.7%0.63%$30.05 - $35.42 $ 43.5733%1874476
Vanguard Health Care Fund 2014-03-31 Sold Out $30.05 - $35.42 $ 43.5733%0
Joel Greenblatt 2013-12-31 Sold Out 0.01%$33.2 - $36.48 $ 43.5724%0
Vanguard Health Care Fund 2013-12-31 New Buy$33.2 - $36.48 $ 43.5724%24624
Mariko Gordon 2013-09-30 Reduce -5.51%0.2%$29.01 - $34.54 $ 43.5735%2399098
Vanguard Health Care Fund 2013-09-30 Sold Out 0.04%$29.01 - $34.54 $ 43.5735%0
Joel Greenblatt 2013-09-30 Reduce -52.74%0.02%$29.01 - $34.54 $ 43.5735%12717
Joel Greenblatt 2013-06-30 Reduce -86.61%0.23%$25.38 - $30.63 $ 43.5753%26908
Joel Greenblatt 2012-12-31 Add 210.51%0.14%$20.25 - $24.09 $ 43.57100%170476
Joel Greenblatt 2012-09-30 Reduce -22%0.03%$21.71 - $24.63 $ 43.5787%54902
Joel Greenblatt 2012-03-31 Add 101.22%0.07%$16.82 - $21.31 $ 43.57136%78962
George Soros 2011-12-31 Sold Out 0.06%$14.25 - $19.03 $ 43.57158%0
Joel Greenblatt 2011-12-31 Add 49.45%0.03%$14.25 - $19.03 $ 43.57158%39241
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Healthsouth Corp

SymbolPriceYieldDescription
HSRPP1464.373.306 1/2% Conv Perp Pfd Shs Series -A-
HLSHP0.000.00Conv Pfd Shs Series A -144A

Ratios

vs
industry
vs
history
P/E(ttm) 28.30
HLS's P/E(ttm) is ranked higher than
80% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 44.30 vs. HLS: 28.30 )
HLS' s 10-Year P/E(ttm) Range
Min: 1.71   Max: 32.2
Current: 28.3

1.71
32.2
Forward P/E 16.34
HLS's Forward P/E is ranked higher than
88% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 25.38 vs. HLS: 16.34 )
N/A
PE(NRI) 28.70
HLS's PE(NRI) is ranked higher than
79% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 43.00 vs. HLS: 28.70 )
HLS' s 10-Year PE(NRI) Range
Min: 1.84   Max: 181.64
Current: 28.7

1.84
181.64
P/B 8.50
HLS's P/B is ranked higher than
57% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.04 vs. HLS: 8.50 )
HLS' s 10-Year P/B Range
Min: 7.07   Max: 191.71
Current: 8.5

7.07
191.71
P/S 1.90
HLS's P/S is ranked higher than
68% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. HLS: 1.90 )
HLS' s 10-Year P/S Range
Min: 0.4   Max: 3.95
Current: 1.9

0.4
3.95
PFCF 14.90
HLS's PFCF is ranked higher than
88% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 45.47 vs. HLS: 14.90 )
HLS' s 10-Year PFCF Range
Min: 1.77   Max: 16.49
Current: 14.9

1.77
16.49
POCF 9.17
HLS's POCF is ranked higher than
86% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 17.44 vs. HLS: 9.17 )
HLS' s 10-Year POCF Range
Min: 1.53   Max: 9.22
Current: 9.17

1.53
9.22
EV-to-EBIT 11.16
HLS's EV-to-EBIT is ranked higher than
94% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 22.61 vs. HLS: 11.16 )
HLS' s 10-Year EV-to-EBIT Range
Min: -35.1   Max: 90.2
Current: 11.16

-35.1
90.2
PEG 1.73
HLS's PEG is ranked higher than
94% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 1.73 )
HLS' s 10-Year PEG Range
Min: 1.05   Max: 2.66
Current: 1.73

1.05
2.66
Shiller P/E 13.40
HLS's Shiller P/E is ranked higher than
97% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 90.55 vs. HLS: 13.40 )
HLS' s 10-Year Shiller P/E Range
Min: 5.19   Max: 41.57
Current: 13.4

5.19
41.57
Current Ratio 1.52
HLS's Current Ratio is ranked higher than
79% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. HLS: 1.52 )
HLS' s 10-Year Current Ratio Range
Min: 0.6   Max: 6.95
Current: 1.52

0.6
6.95
Quick Ratio 1.52
HLS's Quick Ratio is ranked higher than
82% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. HLS: 1.52 )
HLS' s 10-Year Quick Ratio Range
Min: 0.6   Max: 6.95
Current: 1.52

0.6
6.95
Days Sales Outstanding 40.88
HLS's Days Sales Outstanding is ranked higher than
81% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 49.96 vs. HLS: 40.88 )
HLS' s 10-Year Days Sales Outstanding Range
Min: 40.54   Max: 89.44
Current: 40.88

40.54
89.44

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.80
HLS's Dividend Yield is ranked higher than
64% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 1.43 vs. HLS: 1.80 )
HLS' s 10-Year Dividend Yield Range
Min: 0.5   Max: 2.07
Current: 1.8

0.5
2.07
Dividend Payout 0.52
HLS's Dividend Payout is ranked higher than
78% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 0.52 )
HLS' s 10-Year Dividend Payout Range
Min: 0.21   Max: 0.4
Current: 0.52

0.21
0.4
Yield on cost (5-Year) 1.80
HLS's Yield on cost (5-Year) is ranked higher than
50% of the 189 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. HLS: 1.80 )
HLS' s 10-Year Yield on cost (5-Year) Range
Min: 0.5   Max: 2.07
Current: 1.8

0.5
2.07
Share Buyback Rate 2.00
HLS's Share Buyback Rate is ranked higher than
93% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: -1.40 vs. HLS: 2.00 )
HLS' s 10-Year Share Buyback Rate Range
Min: 2   Max: -31.9
Current: 2

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.20
HLS's Price/DCF (Projected) is ranked higher than
86% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.42 vs. HLS: 1.20 )
HLS' s 10-Year Price/DCF (Projected) Range
Min: 0.57   Max: 209.14
Current: 1.2

0.57
209.14
Price/Median PS Value 1.70
HLS's Price/Median PS Value is ranked higher than
61% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. HLS: 1.70 )
HLS' s 10-Year Price/Median PS Value Range
Min: 0.42   Max: 3.45
Current: 1.7

0.42
3.45
Price/Peter Lynch Fair Value 1.70
HLS's Price/Peter Lynch Fair Value is ranked higher than
93% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 1.70 )
HLS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.1   Max: 5.91
Current: 1.7

0.1
5.91
Earnings Yield (Greenblatt) 9.00
HLS's Earnings Yield (Greenblatt) is ranked higher than
93% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 4.80 vs. HLS: 9.00 )
HLS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 16.5
Current: 9

1.1
16.5
Forward Rate of Return (Yacktman) 22.31
HLS's Forward Rate of Return (Yacktman) is ranked higher than
88% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 11.08 vs. HLS: 22.31 )
HLS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.2   Max: 26.7
Current: 22.31

3.2
26.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, DVA, FSNUY, BDUUF, SKHCY » details
Traded in other countries:HSRPP.USA, HSOA.Germany,
HealthSouth Corp was organized as a Delaware corporation in February 1984. It is a provider of inpatient rehabilitative health care services in the United States. The Company's inpatient rehabilitation hospitals offer specialized rehabilitative care to diagnose and patient care services. Patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals including 2 hospitals that operate as joint ventures which it account for using the equity method of accounting, 20 outpatient rehabilitation satellite clinics operated by its hospitals and 25 licensed, hospital-based home health agencies. In addition to HealthSouth hospitals, it manages three inpatient rehabilitation units through management contracts. While it's national network of inpatient hospitals in 28 states and Puerto Rico, its inpatient hospitals are located in the eastern half of the United States and Texas. The Company's inpatient rehabilitation hospitals compete with rehabilitation units, many of which are within acute care hospitals, and skilled nursing facilities in the market. It treats patients of all ages. Its patients are persons aged 65 years and older. The Company is subject to significant federal, state, and local regulation.
» More Articles for HLS

Headlines

Articles On GuruFocus.com
Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 
26.25% Annual Return With Lobbying Stocks? Here Is How It Works Nov 21 2014 
5 Stocks Building Long-Term Wealth With Increased Dividends Jul 28 2014 
"Thrift, fearlessness, resilience, hard work" - What Makes Mariko Gordon Our Newest Guru Dec 07 2013 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
physical therepy Jan 09 2013 
physical therepy Jan 09 2013 
HEALTHSOUTH Corp. Reports Operating Results (10-K) Feb 24 2011 
HealthSouth Reports Results for Second Quarter 2009 and Increases 2009 Guidance Aug 04 2009 
HealthSouth Declares Dividend on 6.5 Percent Series A Convertible Perpetual Preferred Stock Dec 18 2008 


More From Other Websites
HEALTHSOUTH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 23 2015
New Highs: Income Stocks Dominate; TSM Breaks Out Jan 22 2015
HealthSouth Announces Date Of 2014 Fourth Quarter Earnings Conference Call Jan 21 2015
HealthSouth Corporation -- Moody's upgrades HealthSouth's sr. unsecured notes to Ba3; Ba3 CFR... Jan 21 2015
HealthSouth Announces Pricing Of $400 Million Senior Notes Offering Jan 20 2015
HealthSouth Corporation -- Moody's says HealthSouth's ratings unchanged on offering of sr. notes;... Jan 20 2015
HealthSouth Announces Launch Of $300 Million Senior Notes Offering Jan 20 2015
HealthSouth Eyes Add-on Acquisitions for Its Home Healthcare Platform Jan 20 2015
Will HEALTHSOUTH (HLS) Crush Estimates at Its Next Earnings Report? - Tale of the Tape Jan 19 2015
DaVita's Inorganic Growth Initiatives Look Impressive - Analyst Blog Jan 16 2015
HEALTHSOUTH CORP Files SEC form 8-K, Regulation FD Disclosure Jan 13 2015
HEALTHSOUTH CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets Jan 02 2015
HealthSouth Completes Acquisition of Encompass Home Health and Hospice Jan 02 2015
HealthSouth Corporation -- Moody's affirms HealthSouth's Ba3 CFR; new term loan rated Baa3; sr.... Dec 23 2014
HEALTHSOUTH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 23 2014
Will HEALTHSOUTH (HLS) Crush Estimates at Its Next Earnings Report? Dec 12 2014
HealthSouth To Present At The 33rd Annual J.P. Morgan 2015 Healthcare Conference Dec 10 2014
HEALTHSOUTH CORP Files SEC form 8-K, Change in Directors or Principal Officers Dec 08 2014
It was another slow, low volume, lackluster trading session Nov 24 2014
HEALTHSOUTH CORP Files SEC form 8-K, Regulation FD Disclosure Nov 24 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK